Gland Pharma Ltd - Company Profile

Q: Who are the current directors of Gland Pharma Ltd?

The current directors of Gland Pharma Ltd are Essaji Goolam Vahanvati, Udo Jahannes Vetter, Jia Ai Zhang, Srinivas Sadu, Naina Lal Kidwai, Sampath Kumar Pallerlamudi, Ravi Shekhar Mitra, Shyamakant Binda Giri, Satyanarayana Murthy Chavali, Wenjie Zhang, Wei Huang, Shyamakant Binda Giri.

It is a healthcare public limited company based in Medchal Malkajgiri District Hyderabad, Telangana, India, established in 1978.

1978 Medchal Malkajgiri District Hyderabad, Telangana, India Active

Last Updated: January 05, 2026

Access Report

About Gland Pharma Ltd

Gland Pharma Ltd, a active public limited company, was established on 20 March 1978 in Medchal Malkajgiri District Hyderabad, Telangana, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: L24239TG1978PLC002276. Registered under ROC Roc Hyderabad. it is listed on BSE: 543245 and NSE: GLAND. It has an authorized capital of ₹56.30 Cr and a paid-up capital of ₹16.48 Cr.

Formerly known as Gland Pharma Pvt Ltd. It upholds a compliant status. In 2022, it reported revenue of ₹4,624.65 Cr and a net worth of ₹7,158.23 Cr. Employing 4,769 professional, Its leadership includes Essaji Goolam Vahanvati (Director), Udo Jahannes Vetter (Director), Jia Ai Zhang (Director). Past directors included Essaji Goolam Vahanvati, Udo Jahannes Vetter, Karan Singh Swani. It holds no open charges and ₹566.83 Cr settled loans. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at Sy.No.143-148,150 &151,Near Gandi Maisamma X Roads D.P.Pally,Dundigal, Dundigal - Gandimais, Amma(M), Medchal Malkajgiri District Hyderabad, Telangana, 500043.

Company Details

CIN/LLPIN
L24239TG1978PLC002276
Registration Number
002276
Incorporation Date
20 March 1978
Authorized Capital
₹56.30 Cr
Paid-Up Capital
₹16.48 Cr
ROC Code
Roc Hyderabad
Listing Status
Listed (BSE: 543245, NSE: GLAND)
Company Status
Active

Key Metrics

Authorised Capital ₹ 56.30 Cr as on 05-01-2026
Paid Up Capital ₹ 16.48 Cr as on 05-01-2026
Company Age 47 Year, 10 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 566.83 Cr as on 05-01-2026
Revenue Growth **** 28.55% (FY 2022)
Profit Growth **** 21.58% (FY 2022)
Ebitda **** 16.00% (FY 2022)
Net Worth 21.26% (FY 2022)
Total Assets **** 20.60% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Gland Pharma Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Gland Pharma Ltd?

Current Directors

Name	Designation	Appointment Date	Status
Essaji Goolam Vahanvati	Director	30 Sep 2020	Current
Udo Jahannes Vetter	Director	07 Feb 2018	Current
Jia Ai Zhang	Director	17 May 2021	Current
Naina Lal Kidwai	Director	17 May 2021	Current
Shyamakant Binda Giri	Ceo	16 Jan 2025	Current
Satyanarayana Murthy Chavali	Director	20 Nov 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	30 Sep 2020	Past
Pramod Abcsdd	Director	03 Oct 2017	Past
Pramod Abcsdd	Nominee Director	03 Oct 2017	Past
Pramod Abcsdd	Nominee Director	20 Nov 2020	Past
Pramod Abcsdd	Director	30 Aug 2022	Past
Pramod Abcsdd	Director	26 Mar 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gland Pharma.

Gland Pharma Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 28.55% increase. The company also saw a substantial improvement in profitability, with a 21.58% increase in profit. The company's net worth Soared by an impressive increase of 21.26%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

28.55%

*******

Revenue from Operations

*******

27.08%

*******

Total Assets

*******

20.60%

*******

Profit or Loss

*******

21.58%

*******

Net Worth

*******

21.26%

*******

EBITDA

*******

16.00%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gland Pharma?

In 2023, Gland Pharma had a promoter holding of 57.86% and a public holding of 42.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹5,668,300,000.00

Charges Breakdown by Lending Institutions

Syndicate Bank : 292.53 Cr
The Bank Of Nova Scotia : 140.00 Cr
Icici Bank Limited : 100.00 Cr
Export Import Bank Of India : 30.80 Cr
Technology Development Board : 3.50 Cr

Latest Charge Details

Date	Lender	Amount	Status
10 Sep 2012	Icici Bank Limited	₹100.00 Cr	Satisfied
30 Jun 2012	Syndicate Bank	₹100.00 Cr	Satisfied
06 Sep 2005	The Bank Of Nova Scotia	₹140.00 Cr	Satisfied
13 Dec 2004	Syndicate Bank	₹7.50 Cr	Satisfied
09 Sep 2004	Export Import Bank Of India	₹10.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Gland Pharma?

Gland Pharma has a workforce of 4769 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Gland Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gland Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gland Pharma

Recent Activity within the Organization

Annual General Meeting

Gland Pharma Ltd last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was recorded as a recent event.
28 Aug 2025
Balance Sheet

The activity Gland Pharma Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
31 Mar 2025
Director Appointment

The activity Shyamakant Binda Giri was appointed as a Ceo was appointed as a Ceo on 04 Feb 2025 & has been associated with this company since 1 year 7 days . was completed.
04 Feb 2025
Director Appointment

Progress on Shyamakant Binda Giri was appointed as a CEO was appointed as a CEO on 16 Jan 2025 & has been associated with this company since 1 year 26 days . was documented.
16 Jan 2025
Director Appointment

Wei Huang was appointed as a Director was appointed as a Director on 04 Nov 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
04 Nov 2024
Director Appointment

The activity Wenjie Zhang was appointed as a Director was appointed as a Director on 30 Aug 2024 & has been associated with this company since 1 year 5 months . was completed.
30 Aug 2024

Explore recent activity and updates - View Recent Activity